MTOR and tuberous sclerosis: While mTOR inhibition has shown antiepileptogenic effects in preclinical models with hyperactivation of this pathway, such as tuberous sclerosis complex and certain focal cortical dysplasias, other studies have reported no protective effect in different epilepsy models.